SBIR/STTR Research Award
Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device
Award amount
$249,999Program and phase
SBIR · Phase IAward year
2024Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- ADVANCED COOLING TECHNOLOGIES INC
- Proposal award date
- 2024-06-14
- Contract end date
- 2025-01-20
- UEI
- Z8KVZV3DR7J4
- Solicitation number
- 24.1
- Topic code
- DHA241-001
Research abstract
Advanced Cooling Technologies, Inc. (ACT) proposes to develop a high-throughput psoralen/ultraviolet-A (UV-A) based pathogen inactivation system capable of inactivating pathogens at a wide range of volumes from 0.01L to 50L under cGMP conditions. During the Phase I, a 5L prototype reactor capable of delivering UV Dosage through the fluid volume will be demonstrated. A control system software will also be developed to allow complete control over switches necessary to regulate and adjust major process parameters to ensure a complete pathogen inactivation without degrading the antigenic proteins.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- DOD Navy SBIR Icephobic Coating for Air Cycle Machine
- Direct Etched Silicon Wafer Bonding for Micro-Electromechanical Systems (MEMS).
- Variable Emissivity Thermal Control Capability Development for Space based Applications
- Freeze Tolerant Water Heat Pipe and Thermal Switch
- Manufacturing and Measurements of 3D-Printed Porous Structures
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- DOD DHA SBIR Psoralen-UV-A Irradiation Based High-throughput Pathogen Inactivation Device
- VacciRAPTOR: High-throughput, Continuous Flow-Through System for Psoralen-UVA Inactivation
- Psoralen-UV-A Inactivation Based High-throughput Pathogen Inactivation Device
- Psoralen-UV-A Inactivation Based High-throughput Pathogen Inactivation Device
- VacciRAPTOR: High-throughput, Continuous Flow-through Device for Psoralen-UVA Inactivation of Dengue Virus
Research funding history
282 SBIR/STTR records share this UEI (2003–2026). Reported award amounts total $118,415,811. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Energy, National Science Foundation, Department of Agriculture, Department of Health and Human Services